VICTORY CAPITAL MANAGEMENT INC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1040188
San Antonio, TX
Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$179,546
-$223,818 QoQ
Shares Held
129,170
-48.4% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,697,180 across 27 Drug Manufacturers - Specialty & Generic names. AKBA ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in AKBA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $179,546 | 129,170 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $403,364 | 250,537 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $781,831 | 286,385 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $109,316 | 30,032 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $48,506 | 25,264 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $48,793 | 25,681 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $33,455 | 25,345 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $25,323 | 24,827 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $39,925 | 21,817 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $27,923 | 22,519 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $861,256 | 755,488 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $605,636 | 661,898 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $144,336 | 257,744 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $11,437 | 19,822 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $6,266 | 19,830 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $8,464 | 23,978 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $16,523 | 23,013 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $53,494 | 23,670 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $70,119 | 24,347 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $88,928 | 23,464 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $78,491 | 23,188 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $63,053 | 22,519 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $53,184 | 21,189 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $303,200 | 22,327 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $143,686 | 18,956 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||